Top

Published in:

01-07-2015 | Editorial

Do we need a pharmacist in the ICU?

Authors: Clarence Chant, Norman F. Dewhurst, Jan O. Friedrich

Published in: Intensive Care Medicine | Issue 7/2015

Excerpt

On the surface, the answer to the question of the title of this editorial seemed to be a rhetorical and obvious yes. This is not because two pharmacists are involved in authoring this editorial, but because there is a substantial amount of literature—arguably more than which exists for any other clinical team member in the ICU and likely more than some of the standard-of-care interventions (such as mechanical ventilation)—which linked the presence of a pharmacist in an ICU to improved patient outcomes. …

Erstad BL, Haas CE, O’Keeffe T, Hokula CA, Parrinello K, Theodorou AA (2011) Interdisciplinary patient care in the intensive care unit: focus on the pharmacist. Pharmacotherapy 31(2):128–137PubMedCrossRef

Brilli RJ, Spevetz A, Branson RD, Campbell GM, Cohen H, Dasta JF et al (2001) Critical care delivery in the intensive care unit: defining clinical roles and the best practice model. Crit Care Med 29(10):2007–2019PubMedCrossRef

Leape LL, Cullen DJ, Clapp MD, Burdick E, Demonaco HJ, Erickson JI et al (1999) Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA 282(3):267–270PubMedCrossRef

Saokaew S, Maphanta S, Thangsomboon P (2009) Impact of pharmacist’s interventions on cost of drug therapy in intensive care unit. Pharm Pract (Granada) 7(2):81–87

MacLaren R, Bond CA, Martin SJ, Fike D (2008) Clinical and economic outcomes of involving pharmacists in the direct care of critically ill patients with infections. Crit Care Med 36(12):3184–3189PubMedCrossRef

MacLaren R, Bond CA (2009) Effects of pharmacist participation in intensive care units on clinical and economic outcomes of critically ill patients with thromboembolic or infarction-related events. Pharmacotherapy 29(7):761–768PubMedCrossRef

Weant KA, Armitstead JA, Ladha AM, Sasaki-Adams D, Hadar EJ, Ewend MG (2009) Cost effectiveness of a clinical pharmacist on a neurosurgical team. Neurosurgery 65(5):946–950PubMedCrossRef

Jiang SP, Zheng X, Li X, Lu XY (2012) Effectiveness of pharmaceutical care in an intensive care unit from China. A pre- and post-intervention study. Saudi Med J 33(7):756–762PubMed

Jiang SP, Zhu ZY, Ma KF, Zheng X, Lu XY (2013) Impact of pharmacist antimicrobial dosing adjustments in septic patients on continuous renal replacement therapy in an intensive care unit. Scand J Infectious Dis 45(12):891–899CrossRef

10.

Aljbouri TM, Alkhawaldeh MS, Abu-Rumman AE, Hasan TA, Khattar HM, Abu-Oliem AS (2013) Impact of clinical pharmacist on cost of drug therapy in the ICU. Saudi Pharm J 21(4):371–374PubMedCentralPubMedCrossRef

11.

Klopotowska JE, Kuiper R, van Kan HJ, de Pont AC, Dijkgraaf MG et al (2010) On-ward participation of a hospital pharmacist in a Dutch intensive care unit reduces prescribing errors and related patient harm: an intervention study. Crit Care 14(5):R174PubMedCentralPubMedCrossRef

12.

Devlin JW, Holbrook AM, Fuller HD (1997) The effect of ICU sedation guidelines and pharmacist interventions on clinical outcomes and drug cost. Ann Pharmacother 31(6):689–695PubMed

13.

Montazeri M, Cook DJ (1994) Impact of a clinical pharmacist in a multidisciplinary intensive care unit. Crit Care Med 22(6):1044–1048PubMedCrossRef

14.

Kopp BJ, Mrsan M, Erstad BL, Duby JJ (2007) Cost implications of and potential adverse events prevented by interventions of a critical care pharmacist. Am J Health Syst Pharm 64(23):2483–2487PubMedCrossRef

15.

Moffett BS, Mott AR, Nelson DP, Gurwitch KD (2008) Medication dosing and renal insufficiency in pediatric cardiac intensive care unit: impact of pharmacist consultation. Pediatr Cardiol 29(4):744–748PubMedCrossRef

16.

MacLaren R, Brett McQueen R, Campbell J (2013) Clinical and financial impact of pharmacy services in the intensive care unit: pharmacist and prescriber perceptions. Pharmacotherapy 33(4):401–410PubMedCrossRef

17.

Rudis MI, Brandl KM (2000) Position paper on critical care pharmacy services. Society of Critical Care Medicine and American College of Clinical Pharmacy task force on critical care pharmacy services. Crit Care Med 28(11):3746–3750PubMedCrossRef

18.

Maclaren R, Devlin JW, Martin SJ, Dasta JF, Rudis MI, Bond CA (2006) Critical care pharmacy services in United States hospitals. Ann Pharmacother 40(4):612–618PubMedCrossRef

19.

LeBlanc JM, Seoane-Vazquez EC, Arbo TC, Dasta JF (2008) International critical care hospital pharmacist activities. Intensive Care Med 34(3):538–542PubMedCrossRef

Title: Do we need a pharmacist in the ICU?
Authors: Clarence Chant
Norman F. Dewhurst
Jan O. Friedrich
Publication date: 01-07-2015
Publisher: Springer Berlin Heidelberg
Published in: Intensive Care Medicine / Issue 7/2015
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI: https://doi.org/10.1007/s00134-015-3718-0

At a glance: The STEP trials

Springer Medicine

Do we need a pharmacist in the ICU?

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 7/2015

Making advances in delirium research: coupling delirium outcomes research and data sharing

Common genomic variation in the FER gene: useful to stratify patients with sepsis due to pneumonia?

The strange and conflicting world of nursing

Health-related quality of life following pediatric critical illness

Understanding chlorhexidine decolonization strategies

More than half the families of mobile intensive care unit patients experience inadequate communication with physicians